Adverum Biotechnologies Financial Overview
Adverum Biotechnologies's market cap is currently $96.26M. The company's EPS TTM is $-2.03; its P/E ratio is -0.51; Adverum Biotechnologies is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-1.63. See an overview of income statement, balance sheet, and cash flow financials.
